Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Cross-over Multiple Dose Study Assessing the Analgesic Efficacy and Safety of Oral GRT9906 Compared to Placebo in Subjects With Primary Fibromyalgia Syndrome

NCT03783910 is registered in ClinicalTrials.gov with Grünenthal GmbH as lead sponsor.

NCT NCT03783910
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03783910 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Cross-over Multiple Dose Study Assessing the Analgesic Efficacy and Safety of Oral GRT9906 Compared to Placebo in Subjects With Primary Fibromyalgia Syndrome
Lead sponsor
Grünenthal GmbH
Phase
Phase 2
Overall status
Completed
Start date
September 19, 2005
Completion date
October 20, 2006
Enrollment
90 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

primary fibromyalgia